Algernon Pharmaceuticals (AGNPF) Stock Price, News & Analysis

Company Overview

Algernon Pharmaceuticals Inc. operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia. The company's pipeline includes Ifenprodil, which is in Phase 2b clinical trial for the treatment of idiopathic pulmonary fibrosis and chronic cough; repirinast, which is in Phase 1 clinical trial for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine, which is in Phase 1 clinical trial for the treatment of strokes and traumatic brain injuries. The company was formerly known as Breathtec Biomedical, Inc. and changed its name to Algernon Pharmaceuticals Inc. in July 2015. Algernon Pharmaceuticals Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Key Stats

• Today's Range: $0.05 to $0.05
• 50-Day Range: $0.05 to $0.07
• 52-Week Range: $0.04 to $0.11
• Volume: N/A
• Average Volume: 19,069 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AGNPF Stock Analysis - Frequently Asked Questions

How have AGNPF shares performed this year?

Algernon Pharmaceuticals' stock was trading at $0.0463 on January 1st, 2025. Since then, AGNPF stock has increased by 4.8% and is now trading at $0.0485.

When did Algernon Pharmaceuticals' stock split?

Shares of Algernon Pharmaceuticals split on Friday, March 3rd 2023.The 4-1 split was announced on Friday, March 3rd 2023. The newly created shares were distributed to shareholders after the market closes on Friday, March 3rd 2023. An investor that had 100 shares of stock prior to the split would have 400 shares after the split.

How do I buy shares of Algernon Pharmaceuticals?

Shares of AGNPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/09/2025
• Next Earnings (Estimated): 7/28/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AGNPF
• CIK: 1642178
• Web: algernonpharmaceuticals.com
• Phone: 604-398-4175
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A